A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Stdy to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic or Robotic-assisted Laparoscopic Gastrectomy
Latest Information Update: 26 Oct 2021
At a glance
- Drugs Opiranserin (Primary)
- Indications Postoperative pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Vivozon
- 08 Sep 2021 Results published in the Pain Medicine
- 31 Oct 2017 Status changed from recruiting to completed.
- 28 Sep 2016 Planned End Date changed from 1 May 2018 to 1 Aug 2017.